Docusate Sodium 250 mg recall — Class II (D-0060-2025) · pharmaranks
Class IIOngoing
Docusate Sodium 250 mg recall
FDA recall D-0060-2025 · initiated Nov 11, 2024
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Details
Product
Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose box, www.safecorhealth.com, NDC 48433-101-01
Recalling company
Safecor Health, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
USA nationwide.
Initiated
Nov 11, 2024
FDA report date
Nov 27, 2024
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.